Group One Trading’s Nautilus Biotechnolgy NAUT Stock Holding History

Group One Trading’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$187	Hold	100	–	–	﹤0.01%	7374
2026 Q1	$388	Buy	+100	New	+$246	﹤0.01%	7342
2024 Q1	–	Sell	-12,500	Closed	-$37.4K	–	7655
2023 Q4	$37.4K	Sell	12,500 -1,000	-7%	-$2.86K	﹤0.01%	5295
2023 Q3	$42.7K	Buy	+13,500	New	+$43.9K	﹤0.01%	5252
2023 Q1	–	Sell	-1,500	Closed	-$2.7K	–	7679
2022 Q4	$2.7K	Sell	1,500 -500	-25%	-$965	﹤0.01%	6555
2022 Q3	$4K	Sell	2,000 -1,600	-44%	-$4.02K	﹤0.01%	6939
2022 Q2	$10K	Sell	3,600 -72,800	-95%	-$271K	﹤0.01%	6761
2022 Q1	$332K	Sell	76,400 -222,000	-74%	-$911K	﹤0.01%	4261
2021 Q4	$1.55M	Buy	298,400 +204,000	+216%	+$1.09M	﹤0.01%	2879
2021 Q3	$580K	Buy	+94,400	New	+$752K	﹤0.01%	4024

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Group One Trading's NAUT Position: Q2 2026 in Review

Group One Trading opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 8,197 shares worth $15.3K. The stake represents ﹤0.01% of the portfolio and ranks #6166 among its holdings. This is a return to the name: Group One Trading previously reported a position in NAUT as recently as Q4 2025.

Group One Trading first reported a position in NAUT in Q3 2021 and has held it in 6 quarters since. The position peaked at $415K in Q1 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Group One Trading held 8,197 shares of Nautilus Biotechnolgy worth $15.3K as of Q2 2026.
Nautilus Biotechnolgy was a new Group One Trading position in Q2 2026.
Nautilus Biotechnolgy made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6166 holding.
Group One Trading first reported a position in Nautilus Biotechnolgy in Q3 2021 and has held it in 6 quarters since.
Group One Trading's Nautilus Biotechnolgy position peaked at $415K in Q1 2023.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.